These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 8545121

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. v-mos protein produced by in vitro translation has protein kinase activity.
    Herzog NK, Nash M, Ramagli LS, Arlinghaus RB.
    J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The human urokinase-plasminogen activator gene (PLAU) is located on chromosome 10q24 centromeric to the HOX11 gene.
    Stein PM, Stass SA, Kagan J.
    Genomics; 1993 Apr; 16(1):301-2. PubMed ID: 8098010
    [No Abstract] [Full Text] [Related]

  • 47. Pleiotropic mutants of NIH 3T3 cells with altered regulation in the expression of both type I collagen and fibronectin.
    Setoyama C, Liau G, de Crombrugghe B.
    Cell; 1985 May; 41(1):201-9. PubMed ID: 3995582
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. A signal sequence detection system using secreted protease activity as an indicator.
    Yokoyama-Kobayashi M, Sugano S, Kato T, Kato S.
    Gene; 1995 Oct 03; 163(2):193-6. PubMed ID: 7590265
    [Abstract] [Full Text] [Related]

  • 50. Putative repressor binding sites in the regions mediating transcriptional control of viral and cellular genes.
    Renan MJ.
    Biosci Rep; 1985 Sep 03; 5(9):739-53. PubMed ID: 4084673
    [Abstract] [Full Text] [Related]

  • 51. Localization and structure of v-mos in transformed mouse fibroblasts reverted by long-term interferon treatment to nonmalignancy.
    Kaba A, Jiang PH, Chany-Fournier F, Vignal M, Caterina D, Chany C.
    J Interferon Cytokine Res; 1997 Dec 03; 17(12):739-46. PubMed ID: 9452361
    [Abstract] [Full Text] [Related]

  • 52. Use of antipeptide antibodies to probe the catalytic activity of p37v-mos.
    Singh B, al-Bagdadi F, Liu JX, Arlinghaus RB.
    Virology; 1990 Oct 03; 178(2):535-42. PubMed ID: 2171192
    [Abstract] [Full Text] [Related]

  • 53. Effect of butyrate on the expression of the human preprourokinase gene introduced into Chinese hamster ovary cells.
    Okabayashi K, Kanéda T, Arimura H.
    Cell Struct Funct; 1989 Oct 03; 14(5):579-86. PubMed ID: 2620348
    [Abstract] [Full Text] [Related]

  • 54. The biological effects of antisense mos expression in fibroblasts.
    Tsui L, Ramagli L, Gao C, Pham C, Pandita T, Arlinghaus R, Singh B.
    Int J Oncol; 1997 Dec 03; 11(6):1171-8. PubMed ID: 21528318
    [Abstract] [Full Text] [Related]

  • 55. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.
    Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ.
    World J Gastroenterol; 2005 Feb 07; 11(5):623-8. PubMed ID: 15655810
    [Abstract] [Full Text] [Related]

  • 56. Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate.
    Cirillo G, Casalino L, Vallone D, Caracciolo A, De Cesare D, Verde P.
    Mol Cell Biol; 1999 Sep 07; 19(9):6240-52. PubMed ID: 10454570
    [Abstract] [Full Text] [Related]

  • 57. Signaling pathways in Ras-mediated tumorigenicity and metastasis.
    Webb CP, Van Aelst L, Wigler MH, Vande Woude GF.
    Proc Natl Acad Sci U S A; 1998 Jul 21; 95(15):8773-8. PubMed ID: 9671754
    [Abstract] [Full Text] [Related]

  • 58. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
    Lengye E, Singh B, Gum R, Nerlov C, Sabichi A, Birrer M, Boyd D.
    Oncogene; 1995 Dec 21; 11(12):2639-48. PubMed ID: 8545121
    [Abstract] [Full Text] [Related]

  • 59. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
    Lengyel E, Gum R, Stepp E, Juarez J, Wang H, Boyd D.
    J Cell Biochem; 1996 Jun 01; 61(3):430-43. PubMed ID: 8761947
    [Abstract] [Full Text] [Related]

  • 60. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.
    Besser D, Urich M, Sakaue M, Messerschmitt A, Ballmer-Hofer K, Nagamine Y.
    Oncogene; 1995 Dec 07; 11(11):2383-91. PubMed ID: 8570190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.